trending Market Intelligence /marketintelligence/en/news-insights/trending/vlyi662AT0k7RP3LelPbIQ2 content esgSubNav
In This List

Northwest Biotherapeutics issues common stock, warrants in private placement

Blog

Insight Weekly: M&A players predict 2023 activity; SPAC IPOs dip; 2022 capacity retirements up

Blog

Insight Weekly: Recession risk persists; Banks pull back from crypto; 2022 laggard stocks rally

Blog

Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage

Blog

Insight Weekly: Inflation eases; bank M&A slows; top companies boost market share


Northwest Biotherapeutics issues common stock, warrants in private placement

Northwest Biotherapeutics Inc. sold 5.0 million common shares at 20 cents apiece to an unaffiliated investor.

The company also issued to the investor 2.5 million class D warrants exercisable at 23 cents per share for a period of two years, and 2.5 million class D warrants exercisable at 30 cents per share for a period of two years, for an aggregate of $1.0 million.